GGrantIndex
Sort

141,003 grants matching cytokine

Hydrogel microparticle technology for high-throughout screening of chimeric antigen receptor-T cells based on single cell effector function

$754,792
Joseph De Rutte · Partillion Bioscience Corporation · R44 · FY2023 · GM

Engineering personalized micro-tumor ecosystems

$754,767
Shiladitya Sengupta · Brigham And Women'S Hospital · U01 · FY2018 · CA

Pathogenic mechanisms of chronic lung sequelae following respiratory viral infection

$754,729
Lianghui Zhang · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL

Inflammatory Response in Influenza Virus Infection

$754,701
Thomas M Moran · Icahn School Of Medicine At Mount Sinai · U01 · FY2009 · AI

Mechanisms and Therapeutic Targeting of T cell Regulation in Heart Allograft Recipient Monkeys

$754,653
Mohamed B Ezzelarab · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · AI

Immune, hormonal, and muscle mitochondrial determinants of recovery in Acute Respiratory Distress Syndrome survivors

$754,643
Matthew R Baldwin · Columbia University Health Sciences · R01 · FY2023 · HL

A low-profile copper intrauterine device that delivers long-acting contraception an

$754,528
Kim A. Woodrow · University Of Washington · R01 · FY2021 · AI

Effective Therapies for Ocular Injuries by Vesicating Agents

$754,523
Rajesh Agarwal · University Of Colorado Denver · U01 · FY2012 · EY

Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors

$754,519
Christopher C. Derenzo · St. Jude Children'S Research Hospital · R01 · FY2025 · CA

Discovery of host genetic elements affecting response to immune checkpoint inhibitors

$754,511
Edison Tak-Bun Liu · Jackson Laboratory · R01 · FY2025 · CA

SenSE:Wearable hybrid biochemical and biophysical sensing systems integrated with robust artificial intelligence for monitoring COVID-19 patients

$754,496
Yi Zhang · University Of Connecticut · · FY2020 · ENG

Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA

$754,495
Vladimir P Torchilin · Northeastern University · U54 · FY2012 · CA

Inflammation, BBB disruption, and Reward Function in the Pathogenesis of Depression among PWH

$754,485
Vilma Gabbay · Albert Einstein College Of Medicine · R01 · FY2023 · MH

Impact of illicit drugs, HIV, and ART on neuroinflammation and BBB disruption

$754,479
Joan Weinberger Berman · Albert Einstein College Of Medicine · R01 · FY2020 · DA

E3 Ligase-Mediated Immunosuppression in Acute Lung Injury

$754,344
Rama K Mallampalli · Ohio State University · R01 · FY2025 · HL

Structure-guided engineering to increase respiratory syncytial virus G protein immunogenicity

$754,322
Rebecca Michelle Dubois · University Of California Santa Cruz · R01 · FY2024 · AI

Structure-guided engineering to increase respiratory syncytial virus G protein immunogenicity

$754,322
Rebecca Michelle Dubois · University Of California Santa Cruz · R01 · FY2023 · AI

Structure-guided engineering to increase respiratory syncytial virus G protein immunogenicity

$754,322
Rebecca Michelle Dubois · University Of California Santa Cruz · R01 · FY2025 · AI

Role of the innate immune defenses in viral infections

$754,276
Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK

Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance

$754,229
Andrew D Wells · Children'S Hosp Of Philadelphia · R01 · FY2023 · AI

Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance

$754,229
Andrew D Wells · Children'S Hosp Of Philadelphia · R01 · FY2024 · AI

Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance

$754,229
Andrew D Wells · Children'S Hosp Of Philadelphia · R01 · FY2022 · AI

Precision immunoprofiling to reveal diagnostic biomarkers of latent TB infection

$754,111
Ryan C Bailey · University Of Michigan At Ann Arbor · R01 · FY2019 · AI

Tuberculosis Immunopathogenesis During Superinfection with SARS-CoV2

$754,096
Adel M Talaat · University Of Wisconsin-Madison · R01 · FY2023 · AI

Inflammation and Colorectal Neoplasia

$754,094
Andrew T Chan · Massachusetts General Hospital · R01 · FY2016 · CA